THE DEAL, AT A GLANCE
From the announcementInflammatix
01Who is involvedBacked by B Capital, NorthpondFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedInflammatix raised $102M Series CFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersInflammatix is positioned around FDA-cleared emergency department use of TriVerity, an AI blood test intended to distinguish bacterial from viral infection and support…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Inflammatix · Financing Record
Explore source-linked visual explanations for Inflammatix. Unsupported claims are withheld while source review continues.
Record 873 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →